RxDoctor Payments DataLook up a doctor →

Pamela Tittle

Physician Assistant · Anchorage, AKNPI 1417340282

Payments from drug & device makers

$6,702in general payments, 2019–2025

Across 263 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Sumitomo Pharma America, Inc.$685
  • Pfizer$425
  • AstraZeneca$404
  • E.r. Squibb & Sons, L.L.C.$315
  • Novartis$288
  • plus $3K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)39$1,133
Sumitomo Pharma America, Inc.22$685
Pfizer22$425
AstraZeneca(2 entities)18$404
E.r. Squibb & Sons, L.L.C.12$315
Novartis12$288
Seagen Inc.8$229
Daiichi Sankyo Inc.5$218
Astellas Pharma US Inc8$215
AbbVie8$178
AVEO Pharmaceuticals, Inc.4$166
Boehringer Ingelheim7$153
Accord Healthcare, Inc.4$153
180 Medical, Inc.5$129
Pharmacyclics LLC, An Abbvie Company5$121
Amgen5$120
Regeneron Healthcare Solutions, Inc.4$120
Endo USA, Inc.5$116
Bristol Myers Squibb4$101
Urogen Pharma, Inc.4$96
Coherus Oncology, Inc.4$76
Bayer4$73
Gilead3$64
EMD Serono, Inc.3$61
Myriad Genetic Laboratories, Inc.1$59
Blueprint Medicines Corporation2$50
Laborie Medical Technologies Corp.1$47
Deciphera Pharmaceuticals Inc.2$47
Ferring Pharmaceuticals Inc.2$45
Merck2$43
Beigene USA, Inc.2$40
Agios Pharmaceuticals, Inc.2$38
Incyte Corporation2$38
Eisai Inc.2$37
Sun Pharmaceutical Industries Inc.2$32
Acrotech Biopharma Inc.2$31
Ipsen Biopharmaceuticals, Inc1$30
GSK2$29
Taiho Oncology, Inc.1$28
Adaptive Biotechnologies Corporation1$27
Lilly USA, LLC1$25
Rigel Pharmaceuticals, Inc.1$25
ABC Home Medical Supply, Inc.1$25
G1 Therapeutics, Inc.1$24
Jazz Pharmaceuticals Inc.1$24
Sanofi1$24
Kyowa Kirin, Inc.1$22
Morphosys, US Inc.1$22
Chiesi USA, Inc.1$22
Spectrum Pharmaceuticals Inc.1$22
Olympus America Inc.1$22
Sobi, Inc1$21
Dendreon Pharmaceuticals LLC1$20
Puma Biotechnology, Inc.1$20
Mirati Therapeutics, Inc.1$20
Array Biopharma Inc1$18
Alnylam Pharmaceuticals Inc.1$18
Foundation Medicine, Inc.1$18
Myovant Sciences Inc.1$16
Servier Pharmaceuticals LLC1$16

How this compares

$6,702 in reported general payments places this provider in the 95th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska →

Medicare billing

Part B allowed, 2024
$376,442
Medicare patients
477
Services billed
23,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Anchorage

See the full list for Alaska →

Where these figures come from

Is this you, or does something look wrong? →